Review
doi: 10.1093/eurheartj/eht142.
Epub 2013 Apr 26.
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
Affiliations
- PMID: 23625211
- DOI: 10.1093/eurheartj/eht142
Item in Clipboard
Review
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
Eur Heart J.
2013 Aug.
Free article
Abstract
In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.
Keywords: Diabetes; Medical therapy; Vascular disease.
Similar articles
-
Medical management of peripheral artery disease in diabetes mellitus.Eur Heart J. 2015 Jun 21;36(24):1494-5. Eur Heart J. 2015. PMID: 26295080 No abstract available.
-
The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.Dan Med J. 2012 Sep;59(9):B4514. Dan Med J. 2012. PMID: 22951205 Review.
-
Outcome studies in type 2 diabetes.Curr Med Res Opin. 2005;21 Suppl 1:S41-8. doi: 10.1185/030079905X36477. Curr Med Res Opin. 2005. PMID: 15811198 Review.
-
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).Diabet Med. 2009 Jan;26(1):53-60. doi: 10.1111/j.1464-5491.2008.02633.x. Diabet Med. 2009. PMID: 19125761
-
[Diabetes mellitus and coronary artery disease. Update on diagnosis and drug therapy].Dtsch Med Wochenschr. 2007 May 11;132(19):1034-8. doi: 10.1055/s-2007-979377. Dtsch Med Wochenschr. 2007. PMID: 17476633 Review. German. No abstract available.
Cited by
-
Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice.Diabetes Metab J. 2024 May;48(3):390-404. doi: 10.4093/dmj.2023.0109. Epub 2024 Feb 2. Diabetes Metab J. 2024. PMID: 38310882 Free PMC article.
-
Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.J Vasc Surg. 2018 Nov;68(5):1455-1464.e1. doi: 10.1016/j.jvs.2018.01.055. J Vasc Surg. 2018. PMID: 30360841 Free PMC article.
-
NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus.Cells. 2019 Dec 8;8(12):1595. doi: 10.3390/cells8121595. Cells. 2019. PMID: 31817997 Free PMC article.
-
Arterial Stiffness, Biomarkers of Liver Fat, and the Development of Metabolic Dysfunction in Metabolically Healthy Population: A Prospective Study.Front Cardiovasc Med. 2022 Jun 9;9:928782. doi: 10.3389/fcvm.2022.928782. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35811692 Free PMC article.
-
Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-κB (NF-κB).Med Sci Monit. 2019 Feb 15;25:1232-1241. doi: 10.12659/MSM.913244. Med Sci Monit. 2019. PMID: 30767945 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
